Increasing Clinical Trial Participation in Native Hawaiian, Pacific Islander, and Asian Communities

Author(s)

Julia Takata, MS, Kauilaonalani Tengan, BA, Anela Ramos, BS, Deborah Taira, ScD, Todd B. Seto, MD, MPH, Mona S. Ranken, MD;
The Queen's Medical Center, Honolulu, HI, USA

Presentation Documents

OBJECTIVES: To identify strategies for increasing clinical trial participation, particularly for Native Hawaiian (NH), Pacific Islander (PI), and Asian Populations.
METHODS: Key informant eligibility criteria included: 1) experience working with NH, PI, or Asian populations; and 2) fluent in English. Two interviewers conducted 30-minute virtual interviews with 20 key informants. Key informants included clinical researchers, physicians, academicians, and community members, who were recruited based on existing networks and snowball sampling. De-identified transcripts were analyzed using Rapid Qualitative Analysis, which included summarizing interviews in key domains on templates, transferring them to a matrix, and generating key takeaways. Institutional Review Board approval was obtained from The Queen’s Medical Center, Hawaii.
RESULTS: Sixty percent of key informants were women; 25% were between 18 and 39 years; 55% were between 40 and 64 years; and 20% were 65 years or older. A majority (75%) of key informants had more than 10 years of professional experience working with NH, PI, or Asian communities. All key informants surveyed stated that improving access to clinical trials would benefit NH, PI, or Asian communities. Key informants suggested focusing on three main areas for increasing clinical trial participation in NH, PI, and Asian populations: 1) Providing unique accommodations specific to the community’s needs; 2) Addressing historical trauma and medical mistrust; 3) Emphasizing potential community benefits of clinical research.
CONCLUSIONS: Key informants suggested that clinical trial participation can be increased by addressing mistrust, highlighting community benefits, and providing specific accommodations for each community. In addition to these three main areas, the key informants conveyed that it would be critical to maintain a long-term relationship with each of the NH, PI, or Asian communities to continue building trust and their involvement in clinical trials.

Conference/Value in Health Info

2025-05, ISPOR 2025, Montréal, Quebec, CA

Value in Health, Volume 28, Issue S1

Code

PCR229

Topic

Patient-Centered Research

Topic Subcategory

Patient Behavior and Incentives

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×